about
Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene deliveryHomogeneous Biosensing Based on Magnetic Particle LabelsStem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An OverviewNanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agentsMolecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsBasic MR relaxation mechanisms and contrast agent designRecent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic AgentsIn vitro cytotoxic evaluation of MgO nanoparticles and their effect on the expression of ROS genesToxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineeringNanoparticles from renewable polymersAn emerging interface between life science and nanotechnology: present status and prospects of reproductive healthcare aided by nano-biotechnologyAir-stable superparamagnetic metal nanoparticles entrapped in graphene oxide matrixPre-clinical characterization of tissue engineering constructs for bone and cartilage regeneration.Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imagingMultimodality and nanoparticles in medical imagingPEG-capped, lanthanide doped GdF3 nanoparticles: luminescent and T2 contrast agents for optical and MRI multimodal imaging.Effect of the nanoparticle synthesis method on dendronized iron oxides as MRI contrast agents.Magnetic colloidal supraparticles: design, fabrication and biomedical applications.Dysprosium complexes and their micelles as potential bimodal agents for magnetic resonance and optical imaging.Developing Fe3O4 nanoparticles into an efficient multimodality imaging and therapeutic probe.Superparamagnetic iron oxide nanoparticles stabilized by a poly(amidoamine)-rhenium complex as potential theranostic probe.Highly water-dispersible surface-modified Gd(2)O(3) nanoparticles for potential dual-modal bioimaging.Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.Synthesis of Au-Fe3O4 heterostructured nanoparticles for in vivo computed tomography and magnetic resonance dual model imaging.Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging.One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.Nanoparticles based on star polymers as theranostic vectors: endosomal-triggered drug release combined with MRI sensitivity.Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents.One-step, room-temperature synthesis of glutathione-capped iron-oxide nanoparticles and their application in in vivo T1-weighted magnetic resonance imaging.Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect.MR imaging probes: design and applications.Binary behaviour of an oxidation-responsive MRI nano contrast agent.An aqueous method for the controlled manganese (Mn(2+)) substitution in superparamagnetic iron oxide nanoparticles for contrast enhancement in MRI.Synthesis of small-sized, porous, and low-toxic magnetite nanoparticles by thin POSS silica coating.Design and optimization of lipid-modified poly(amidoamine) dendrimer coated iron oxide nanoparticles as probes for biomedical applications.Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.Folic acid-targeted magnetic Tb-doped CeF3 fluorescent nanoparticles as bimodal probes for cellular fluorescence and magnetic resonance imaging.Magnetofluorescent micelles incorporating Dy(III)-DOTA as potential bimodal agents for optical and high field magnetic resonance imaging.Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis.
P2860
Q26744195-166A829D-B725-41A9-8ADA-86E5982CAD3CQ26747505-BC102849-847A-4B5F-ACF4-F44190BA803CQ26770087-6537569D-4450-4BC0-9492-C7AAD6935B13Q26824262-E78F44D6-5BA4-4C5A-B411-416B99CFA14FQ27027613-51633613-95E1-4083-BE05-21C00B6075D7Q27692546-F5E67778-65E3-452F-B9DC-910EFA11CED0Q28079607-A71D4FF3-FA68-4757-BC84-AE5F71255DDFQ28393632-0E59A161-E8EB-444E-9312-94CE941E38ADQ28394579-8D8134C0-77D9-487E-9E17-02A1F9E5240AQ28655569-32C8FE43-DD56-4DE3-9190-0061A596528DQ28658189-E0F49852-406E-41E2-BC81-5D4C43E1E615Q28829893-D5C1DC2C-6AA7-4518-84A5-79C8750098C6Q30389472-5ADD9D74-C8D0-40A1-AEA3-1E10AE251B78Q30395463-0F4A1F28-CC17-4D91-8709-B541DA155637Q30407070-8498D1CA-355C-4861-98D5-A24D4E5314E0Q30575680-28A00846-C33E-460C-BC84-12E19C2CC8B0Q30578684-601C9EF3-13AE-4F78-8B6A-13494ED0E0D1Q30664539-53A11ECE-9174-45A0-9A66-FADF8B2563DEQ30677097-78D5BD88-F2ED-4DEC-9E55-9BEE549FAD17Q30678695-01C93CE7-54DE-46DF-843D-12E717F833B5Q30685707-D39649F9-3A2B-417C-B614-DB6A495066AEQ30686496-3506C858-0E96-4249-913E-BC014A476434Q30687386-F6C8E2C4-D411-47AA-8432-1FDED5317E00Q30689242-ACAB3B2A-F4FC-4439-B3C4-90E94AEFDBB3Q30696540-205F8409-9A46-4BFA-B4E2-1DFF3E6E5FD3Q30708177-D49A6D1C-6C2A-4761-B15B-6EA92AD6795EQ30746227-7BB90C0A-1B70-4662-8C34-2DBCA26401BEQ30834488-B754516F-B998-44A7-80FA-457994D36AF8Q30834935-38323AD9-4FB8-4625-8C65-F6EFF625BE8BQ30837537-46EBA6D7-ADE2-4E6A-AFE0-4212F3E55778Q30847182-C3C4F423-EEBF-488C-986C-B8391DAB09E1Q30868199-C19D3D98-5B17-473B-B131-4928AC1B7B7AQ30872930-27C9075B-DA1C-4D91-A8B1-E80B37261247Q30884375-8BC192F0-CB03-40B4-B9D2-058230017520Q30886510-391D1B0A-95E0-42B7-BFD3-690403DB5134Q30917699-EEED80D9-EBF2-49F8-A533-97883097F9A0Q30924405-B8493F21-7AAB-4BFB-8BF5-193C043BD632Q30989338-FD5F4967-59BC-4C6D-A123-F1CA29B11A66Q31044226-D09AFFCE-6EA9-401E-B548-E35404CB4799Q31048535-634479D1-09C9-4750-99D1-098928A514A0
P2860
description
im Juni 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2009
@uk
name
Inorganic Nanoparticles for MRI Contrast Agents
@en
Inorganic Nanoparticles for MRI Contrast Agents
@nl
type
label
Inorganic Nanoparticles for MRI Contrast Agents
@en
Inorganic Nanoparticles for MRI Contrast Agents
@nl
prefLabel
Inorganic Nanoparticles for MRI Contrast Agents
@en
Inorganic Nanoparticles for MRI Contrast Agents
@nl
P2860
P356
P1433
P1476
Inorganic Nanoparticles for MRI Contrast Agents
@en
P2093
In Chan Song
Taeghwan Hyeon
P2860
P304
P356
10.1002/ADMA.200802366
P407
P50
P577
2009-06-05T00:00:00Z